Clinical evaluation of the safety and effectiveness Oral capsules in the prevention and treatment of hair loss
Phase 2
Recruiting
- Conditions
- hair loss.Nonscarring hair loss, unspecifiedL65.9
- Registration Number
- IRCT20190210042676N18
- Lead Sponsor
- Knowledge-based company of Janus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Male aged 18-50 years
General health
Hair Loss Status II, III, IV Based on Norwood Scale
Voluntary participation and signing written informed consent
Exclusion Criteria
Chronic active scalp disease other than hair loss
Using any prescribed drug or OTC for hair loss within the past 3 months
Documented sensitivity to formulation components
Any severe weight loss or strict diet therapy during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hair lost Changes, based on Global photographic review. Timepoint: Before intervention, 8 and 16 weeks after the start of use. Method of measurement: One independent dermatologist will perform clinical assessments in a blinded fashion by scoring every photograph according to the Global photographic review scale .
- Secondary Outcome Measures
Name Time Method Hair count changes. Timepoint: Before intervention, 8 and 16 weeks after the start of use. Method of measurement: Trichoscopy By Fotofinder.